Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Glaucoma is characterized by elevated intraocular pressure that can damage the optic nerve, affecting millions of Americans. If you have glaucoma and are considering GLP-1 medications like semaglutide for weight loss, understanding potential interactions between these therapies is essential before beginning any new treatment regimen.
How GLP-1 Medications Affect Intraocular Pressure and Eye Health
GLP-1 receptor agonists work by stimulating insulin secretion and slowing gastric emptying, leading to reduced appetite and weight loss. However, some patients on GLP-1 drugs have reported eye-related side effects including blurred vision and changes in fluid pressure within the eye. The relationship between semaglutide and intraocular pressure remains an active area of clinical investigation, with case reports suggesting possible connections in certain individuals.
Published case studies indicate that a small number of patients on GLP-1 therapy experienced acute angle-closure glaucoma or increased intraocular pressure. These instances appear to occur rarely and may involve underlying anatomical eye factors that predispose certain people to pressure changes. Your eye care specialist can assess your individual risk profile and help determine whether GLP-1 therapy is appropriate for your specific situation.
Medical Screening Requirements Before Starting Semaglutide with Glaucoma
Before initiating any GLP-1 medication, patients with glaucoma should undergo a comprehensive evaluation by both their primary care physician and ophthalmologist. This screening should include current intraocular pressure measurements, the type of glaucoma diagnosed, and any previous eye surgeries or treatments. PlexusDx recommends written clearance from your eye care team before beginning semaglutide or other GLP-1 compounds, ensuring coordinated medical oversight.
Your doctor should review your complete medical history, including all previous eye conditions, medications that affect ocular pressure, and any family history of glaucoma. Many patients with well-controlled glaucoma—managed through drops, laser treatment, or surgery—have safely pursued GLP-1 therapy under close medical supervision. Open communication between your ophthalmologist and your weight loss provider creates the safest pathway forward.
Alternative Weight Loss Options for Patients with Glaucoma
Patients with glaucoma who want to avoid potential eye pressure complications may explore PlexusDx's comprehensive medication menu beyond standard semaglutide. The Microdose GLP-1 Protocol starts at $129 per month and uses lower peptide concentrations, potentially reducing the risk of systemic side effects while still supporting sustainable weight loss. This option allows individuals with sensitive health conditions to benefit from GLP-1 mechanisms at a gentler dose level.
Lifestyle-based weight management—including structured nutrition, supervised exercise, and behavioral coaching—remains a foundational approach that carries no medication-related eye risks. Many healthcare providers recommend combining modest dietary changes with regular physical activity as a first-line strategy, particularly for patients with known glaucoma. When medication becomes necessary, your PlexusDx provider can work directly with your ophthalmologist to select the safest compound and dosing approach.
Monitoring and Safety During GLP-1 Treatment with Glaucoma
If you and your medical team decide that semaglutide or another GLP-1 medication is appropriate, regular eye pressure monitoring becomes mandatory throughout treatment. Schedule intraocular pressure checks at least every three months during the first year of GLP-1 therapy, more frequently if your ophthalmologist recommends it. Report any new vision changes, eye pain, blurred vision, or halos around lights immediately to both your weight loss provider and eye care specialist.
PlexusDx's Precision Peptide Genetic Test—available as a $99 add-on after your first month of treatment—maps 14 metabolic pathways and 150+ genetic insights that may influence how your body responds to GLP-1 compounds. Understanding your individual genetic predispositions to peptide sensitivity can help your care team select the safest medication option and anticipate potential responses. Continuous safety monitoring, combined with personalized genetic insights, creates a comprehensive safety net for patients managing both weight and eye health.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take semaglutide if I have glaucoma?
Semaglutide may be safe with glaucoma, but only under direct medical supervision and with written clearance from your ophthalmologist. Case reports exist of GLP-1 drugs affecting intraocular pressure in rare instances, making pre-treatment screening and ongoing monitoring essential. PlexusDx requires coordination between your eye care team and weight loss provider before starting any GLP-1 medication.
What eye symptoms should I watch for while on GLP-1 therapy?
Report blurred vision, eye pain, sudden vision loss, halos around lights, or changes in peripheral vision immediately to your healthcare providers. These symptoms could indicate pressure changes or other eye complications that require urgent evaluation. Early detection through regular ophthalmologist visits is your best protection against serious complications.
Can I use PlexusDx semaglutide if my glaucoma is well-controlled?
Well-controlled glaucoma managed through medications, laser surgery, or conventional treatment does not automatically disqualify you from GLP-1 therapy. However, your ophthalmologist must review your current pressure readings and treatment history to confirm it is safe to proceed. PlexusDx starts semaglutide injections at $149 per month, but initiation requires documented medical clearance from your eye specialist.
What is the Microdose GLP-1 Protocol, and is it safer for glaucoma patients?
The Microdose GLP-1 Protocol uses lower concentration GLP-1 compounds starting at $129 per month and may reduce systemic side effects compared to standard dosing. While research on microdose protocols and glaucoma is still emerging, lower drug exposure could theoretically reduce eye pressure risks. Your PlexusDx provider can discuss whether microdosing aligns with your ophthalmologist's recommendations.
How does the Precision Peptide Genetic Test help me if I have glaucoma?
The Precision Peptide Genetic Test ($99 add-on) identifies your genetic sensitivity to key peptide pathways—including GLP1R rs6923761 and other variants—that influence how your body responds to semaglutide and other GLP-1 drugs. This personalized insight allows your PlexusDx provider and ophthalmologist to select the safest medication option and anticipate potential side effects before they occur. Genetic understanding combined with regular eye pressure monitoring creates a more secure treatment plan for patients managing both weight and glaucoma.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Treatment: Do I Still Take My Metformin with Ozempic?
Navigating Your Journey: Can You Take Keto Gummies with Ozempic?